Optimal timing for the resection of pulmonary metastases in patients with colorectal cancer

被引:8
作者
Yamada, Kazunosuke [1 ]
Ozawa, Daigo [1 ]
Onozato, Ryouichi [2 ]
Suzuki, Masaki [1 ]
Fujita, Atsushi [2 ]
Ojima, Hitoshi [1 ]
机构
[1] Gunma Prefectural Canc Ctr, Dept Gastroenterol Surg, Ota, Gunma, Japan
[2] Gunma Prefectural Canc Ctr, Dept Gen Thorac Surg, Ota, Gunma, Japan
关键词
colorectal neoplasms; metastasectomy; pulmonary metastasis; LUNG METASTASES; PROGNOSTIC-FACTORS; SURGICAL INDICATIONS; TUMOR-CELLS; SURVIVAL; RECURRENCE; GUIDELINES; SURGERY; TRIAL; COLON;
D O I
10.1097/MD.0000000000019144
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aims to clarify the surgical treatment time of pulmonary metastasis in patients with colorectal cancer. Early relapse after resection of pulmonary metastasis is often encountered when the interval from the detection of pulmonary metastasis to pulmonary metastasectomy was short. In this retrospective analysis, data of patients with colorectal cancer who underwent surgical treatment of pulmonary metastasis at the Gunma Prefectural Cancer Center, Gunma, from April 2001 through September 2018 were evaluated. The patients were divided into 2 groups. We examined the interval period from the diagnosis of pulmonary metastasis to pulmonary metastasectomy. This period was divided into every 3 months, and the prognosis of each group was compared with clarify the appropriate timing of pulmonary metastasectomy. The primary endpoints were 5-year overall survival and recurrence-free survival rates. The most significant difference was observed when the cutoff value was 9 months (5-year recurrence-free survival 45.8% vs 85.6%, P<.01). No significant difference was found in any background factors between the 2 groups. Twenty-five patients (34.7%) experienced recurrence after pulmonary metastasectomy. The most common site of recurrence was the lung (48%). Among the 12 cases of recurrence of pulmonary metastasis, 11 cases belonged to the <9 months group. A multivariable survival analysis found that the interval period of <9 months was a significant predictor of recurrence. Our study suggests that clinical follow-up for 9 months prior pulmonary metastasectomy in colorectal patients would improve the prognosis.
引用
收藏
页数:6
相关论文
共 35 条
[1]   Nuclear maspin expression: A biomarker for budding assessment in colorectal cancer specimens [J].
Banias, Laura ;
Gurzu, Simona ;
Kovacs, Zsolt ;
Bara, Tivadar ;
Bara, Tivadar, Jr. ;
Jung, Joan .
PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (09) :1227-1230
[2]   Colon Cancer, Version 1.2017 Clinical Practice Guidelines in Oncology [J].
Benson, Al B., III ;
Venook, Alan P. ;
Cederquist, Lynette ;
Chan, Emily ;
Chen, Yi-Jen ;
Cooper, Harry S. ;
Deming, Dustin ;
Engstrom, Paul F. ;
Enzinger, Peter C. ;
Fichera, Alessandro ;
Grem, Jean L. ;
Grothey, Axel ;
Hochster, Howard S. ;
Hoffe, Sarah ;
Hunt, Steven ;
Kamel, Ahmed ;
Kirilcuk, Natalie ;
Krishnamurthi, Smitha ;
Messersmith, Wells A. ;
Mulcahy, Mary F. ;
Murphy, James D. ;
Nurkin, Steven ;
Saltz, Leonard ;
Sharma, Sunil ;
Shibata, David ;
Skibber, John M. ;
Sofocleous, Constantinos T. ;
Stoffel, Elena M. ;
Stotsky-Himelfarb, Eden ;
Willett, Christopher G. ;
Wu, Christina S. ;
Gregory, Kristina M. ;
Freedman-Cass, Deborah .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (03) :370-398
[3]   Role of surgical resection in colorectal lung metastases: analysis of 137 patients [J].
Borasio, Piero ;
Gisabella, Mara ;
Bille, Andrea ;
Righi, Luisella ;
Longo, Marina ;
Tampellini, Marco ;
Ardissone, Francesco .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2011, 26 (02) :183-190
[4]   Causal Model of Survival After Pulmonary Metastasectomy of Colorectal Cancer: A Nationwide Prospective Registry [J].
Embun, Raul ;
Rivas de Andres, Juan J. ;
Call, Sergi ;
de Olaiz Navarro, Beatriz ;
Freixinet, Jorge L. ;
Bolufer, Sergio ;
Jarabo, Jose R. ;
Pajuelo, Nuria ;
Molins, Laureano .
ANNALS OF THORACIC SURGERY, 2016, 101 (05) :1883-1890
[5]   Preoperative Evaluation and Indications for Pulmonary Metastasectomy [J].
Erhunmwunsee, Loretta ;
Tong, Betty C. .
THORACIC SURGERY CLINICS, 2016, 26 (01) :7-+
[6]   A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer [J].
Goldberg, RM ;
Sargent, DJ ;
Morton, RF ;
Fuchs, CS ;
Ramanathan, RK ;
Williamson, SK ;
Findlay, BP ;
Pitot, HC ;
Alberts, SR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) :23-30
[7]   Risk Factors for Survival after Lung Metastasectomy in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis [J].
Gonzalez, Michel ;
Poncet, Antoine ;
Combescure, Christophe ;
Robert, John ;
Ris, Hans Beat ;
Gervaz, Pascal .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (02) :572-579
[8]   Does perioperative chemotherapy improve survival in patients with resectable lung metastases of colorectal cancer? [J].
Guerrera, Francesco ;
Falcoz, Pierre-Emmanuel ;
Renaud, Stephane ;
Massard, Gilbert .
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2017, 24 (05) :789-791
[9]   Surgery of colorectal cancer lung metastases: analysis of survival, recurrence and re-surgery [J].
Guerrera, Francesco ;
Mossetti, Claudio ;
Ceccarelli, Manuela ;
Bruna, Maria Cristina ;
Bora, Giulia ;
Olivetti, Stefania ;
Lausi, Paolo Olivo ;
Solidoro, Paolo ;
Ciccone, Giovannino ;
Ruffini, Enrico ;
Oliaro, Alberto ;
Filosso, Pier Luigi .
JOURNAL OF THORACIC DISEASE, 2016, 8 (07) :1764-+
[10]   METASTASIS OF METASTASES [J].
HOOVER, HC ;
KETCHAM, AS .
AMERICAN JOURNAL OF SURGERY, 1975, 130 (04) :405-411